Clinical News

Commercial medication therapy management programs are gaining in strength and popularity for medical, financial, and practical reasons. In Minnesota, a pilot program for state employees was so successful that two years later it expanded into a program for all fully insured members. Another program is in use by Minnesota Medicaid and General Mills. And in North Carolina, the Asheville Project is still going strong.

On July 23, Eli Lilly and Company announced the Food and Drug Administration (FDA) has approved a new use for its osteoporosis drug FORTEO to treat osteoporosis associated with sustained, systemic glucocorticoid therapy in men and women at high risk of fracture.

The U.S. Food and Drug Administration has announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States.

Carolyn Brackett, PharmD, Associate Professor of Clinical Pharmacy at Ohio State University?s College of Pharmacy believes it?s possible to bring more humanity and human-to-human interaction to pharmacy ? regardless of the area in which they practice.

The Food and Drug Administration has approved Multaq 400 mg tablets to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter.

The Food and Drug Administration (FDA) has announced that it is requiring manufacturers to put a boxed warning on the prescribing information for the smoking cessation drugs Chantix and Zyban.

Record budget problems have pushed California to eliminate funding for the largest poison control system in the nation. Keep reading to find out about a California pharmacy's fight to keep the poison control system going.

Learn more about the 2008 top generic drugs by retail dollars

Find out more about the 200 top branded drugs by retail dollars

The U.S. Food and Drug Administration announced recently the approval of Creon (pancrelipase), a pancreatic enzyme replacement product designed to help patients with cystic fibrosis and others with exocrine pancreatic insufficiency (EPI) digest and absorb nutrients from foods.

In 2009, economic uncertainties, fear of new influenza strains, and pain are contributing to problems with sleeplessness experienced by many among the U.S. population.

Centric Health Resources in St. Louis, Mo., serves patients who have the rarest diseases and need the most expensive drugs.

As rising costs and falling reimbursements cause many physicians to move out of the business of giving specialty-drug infusions, hospitals are taking over the task.

May is National Asthma and Allergy Awareness Month. Several new OTC products are on pharmacy shelves for seasonal sufferers seeking relief.

The New York Senate is considering a bill to permit qualifying seniors to obtain their prescription medications from a Canadian pharmacy group. New York pharmacists oppose any plan to take pharmacy dollars out of the state.

For treatment of many diseases, use of biologic agents continues to grow. In assessment of risk, however, clinical trials may not yield sufficient information.

Students in a University of Florida healthcare risk management class examine the connection between medication errors and patient counseling from the dual perspective of pharmacists and risk managers.

Widespread confusion about the new label format for prescription drugs has sent FDA officials to association meetings around the country, explanations in hand.

The Caverject Impulse Dual Chamber System, a drug delivery device used to treat erectile dysfunction that was withdrawn by the manufacturer, will return to pharmacy shelves, according to Pfizer, Inc.

California may be moving toward a new form of liability. The state Supreme Court declined to hear an appeal from Wyeth in a case the held the drug maker liable for injuries caused by generic versions of Reglan (metoclopramide) made by another manufacturer.

A bipartisan bill that would allow the U.S. Food and Drug Administration (FDA) to approve affordable copies of biotech drugs has been introduced in Congress.

Most medication errors in primary care practices are prescribing errors and, while a majority of those reach the patient, pharmacists are most likely to intercept the mistakes, according to a new study by the Agency for Healthcare Research and Quality.

Pfizer Inc. will begin selling dozens more generic drugs through new deals with an Indian generic company, becoming the latest brand-name drug maker looking to grow its market share in the growing generics market.

Confusion about the three different lamictal starter kits can lead to pharmacy and patient error. There are several things pharmacists can do to ensure that patients use their kits properly.

Medications for sleep disorders may cause patients to sleepwalk, drive, eat, even have sex while asleep. Patients don't often ask for information about sleep medications, so pharmacists must offer it.

Toviaz extended-release tablets win FDA approval for treatment of overactive bladder

New York phamacists train to administer vaccinations for flu and pneumonia

Arizona proposal would expand list of vaccines given by pharmacists

Henry Waxman this week told attendees of the Generic Pharmaceutical Association Annual in Florida that he would work to pass legislation that would allow generic versions of biogenerics and biosimilar pharmaceuticals.

There are more than 50 million children in the US, most of whom receive some sort of medication during their childhood. That may be one reason niche pharmacies are becoming more popular.